These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4756071)

  • 1. [Therapy of heart insufficiency using aldosterone antagonists].
    Krauss J
    Z Allgemeinmed; 1973 Jul; 49(21):989-91. PubMed ID: 4756071
    [No Abstract]   [Full Text] [Related]  

  • 2. [Steroid spirolactones--antagonists of mineralocorticoids].
    Linèt O
    Cesk Farm; 1969 Jun; 18(4):218-26. PubMed ID: 4895579
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of combined captopril-spironolactone therapy of cardiac insufficiency on kidney function and serum electrolyte values].
    Cserhalmi L
    Orv Hetil; 1998 Jan; 139(2):63-6. PubMed ID: 9451904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options].
    Diercks GF; Overdiek JW; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2001 Feb; 145(5):204-8. PubMed ID: 11219145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aldosterone-antagonists in heart surgery. Influence of the pre- and post-operative treatment using specific aldosterone-antagonists].
    Beyer J; Sebening F
    Fortschr Med; 1973 Mar; 91(8):328-34. PubMed ID: 4702389
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of aldactone and veroshpiron in complex therapy of patients with circulation disorders].
    Bezborod'ko BN; Shekhunova MI; Selivonenko VG
    Ter Arkh; 1973 Jan; 45(1):84-6. PubMed ID: 4770028
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic heart insufficiency should be treated also with spironolactone].
    Kjeldsen KP; Nørgaard A; Thygesen K
    Ugeskr Laeger; 1999 Sep; 161(37):5132. PubMed ID: 10523942
    [No Abstract]   [Full Text] [Related]  

  • 8. Spironolactone for heart failure: a worthy addition to therapy.
    Rittenhouse SK
    Adv Nurse Pract; 2001 Jan; 9(1):34-6, 39. PubMed ID: 12416036
    [No Abstract]   [Full Text] [Related]  

  • 9. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of spironolactone in heart failure should be emphasised.
    Mapstone J; Houston B; Gogarty M
    BMJ; 2000 Sep; 321(7262):706-7. PubMed ID: 11202944
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J; Fraccarollo D
    Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The aldosterone antagonist spironolactone prolongs the survival of chronic heart failure patients. The results of the RALES study. The Randomized Aldactone Evaluation Study].
    Schwinger RH
    Dtsch Med Wochenschr; 1999 Aug; 124(34-35):987-8. PubMed ID: 10488324
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-aldosterone therapy in severe heart failure].
    van Guldener C; Donker AJ
    Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1724-6. PubMed ID: 10494316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aldosterone antagonists in coronary insufficiency].
    Osswald H
    Med Klin; 1978 Jan; 73(3):84-8. PubMed ID: 622061
    [No Abstract]   [Full Text] [Related]  

  • 15. New hope for heart failure.
    DeMaria A
    Health News; 1999 Sep; 5(11):1-2. PubMed ID: 10513252
    [No Abstract]   [Full Text] [Related]  

  • 16. Spironolactone in left-sided heart failure: how does it fit in?
    Margo KL; Luttermoser G; Shaughnessy AF
    Am Fam Physician; 2001 Oct; 64(8):1393-8. PubMed ID: 11681781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of verospiron and hypothiazide on the indices of electrolyte metabolism in neuroendocrinological obesity].
    Zhurova MV; Rybina LV
    Vrach Delo; 1980 Nov; (11):97-9. PubMed ID: 7467273
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of spironolactone on C-reactive protein levels in patients with heart disease.
    Godfrey V; Farquharson CA; Macdonald JE; Yee KM; Struthers AD
    Int J Cardiol; 2007 Apr; 117(2):282-4. PubMed ID: 16899309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New evidence for the usefulness of an old drug in the treatment of heart failure].
    Oseguera Moguel J
    Rev Invest Clin; 2000; 52(1):14-6. PubMed ID: 10818804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.